Botanical species · safety record

Satureja thymbra

The EFSA Compendium of Botanicals holds 10 constituent measurements and 2 adverse-effect records for Satureja thymbra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Satureja thymbra L.

10Constituent measurements

2Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Aerial part of plants	Essential oil	1.51 Percent	GC-MS	Resolve DOI
Myrcene	Aerial part of plants	Essential oil	1.19 Percent	GC-MS	Resolve DOI
Myrcene	Unspecified	Essential oil	≥ 2 Percent	GC-MS	Resolve DOI
Myrcene	Unspecified	Essential oil	≤ 2.3 Percent	GC-MS	Resolve DOI
Myrcene	Unspecified	Solvent extraction	≤ 1.8 Percent	GC-FID-MS	No resolvable identifier
Myrcene	Unspecified	Solvent extraction	≥ 0.7 Percent	GC-FID-MS	No resolvable identifier
Quinones	Unspecified	Solvent extraction	≤ 2.1 Percent	GC-FID-MS	No resolvable identifier
Quinones	Unspecified	Solvent extraction	≥ 0.3 Percent	GC-FID-MS	No resolvable identifier
Thymoquinone	Unspecified	Solvent extraction	≥ 0.8 Percent	GC-FID-MS	No resolvable identifier
Thymoquinone	Unspecified	Solvent extraction	≤ 6.1 Percent	GC-FID-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Unspecified	Solvent extraction	—	In vitro	No resolvable identifier
Digestive	Digestive: pancreas	Unspecified	Solvent extraction	—	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Tundis, R., Loizzo, M. R., Menichini, F. Natural Products as alpha-Amylase and alpha-Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update . Mini-reviews in medicinal chemistry, 2010, vol. 10, no. 4, p. 315-331.
Fleisher, Z., Fleisher, A. Extract analyses of Satureja thymbra L. and Thymbra spicata L. aromatic plants of the Holy Land and the Sinai. Part XVII . Journal of essential oil research, 2005, vol. 17, no. 1, p. 32-35.
Figueredo, G., Unver, A., Chalchat, J. C., Arslan, D., Ozcan, M. M. A RESEARCH ON THE COMPOSITION OF ESSENTIAL OIL ISOLATED FROM SOME AROMATIC PLANTS BY MICROWAVE AND HYDRODISTILLATION . Journal of food biochemistry, 2012, vol. 36, no. 3, p. 334-343. DOI
Skoula, M., Grayer, RJ. Volatile oils of Coridothymus capitatus, Satureja thymbra, Satureja spinosa and Thymbra calostachya (Lamiaceae) from Crete . Flavour and fragrance journal, 2005, vol. 20, no. 6, p. 573-576. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature